blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3492080

EP3492080 - DOSING REGIMEN FOR SEDATION WITH CNS 7056 (REMIMAZOLAM) [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  17.11.2023
Database last updated on 05.10.2024
FormerExamination is in progress
Status updated on  27.05.2020
FormerRequest for examination was made
Status updated on  06.12.2019
FormerThe application has been published
Status updated on  03.05.2019
Most recent event   Tooltip17.11.2023Refusal of applicationpublished on 20.12.2023  [2023/51]
Applicant(s)For all designated states
PAION UK Ltd.
Chivers Way Histon
Cambridge CB24 9ZR / GB
[2019/23]
Inventor(s)01 / WILHELM-OGUNBIYI, Karin
Hochscheiter Str. 33
52152 Simmerath / DE
02 / BORKETT, Keith
Carren House
Meadow Lane
Houghton CAMPS PE28 2BP / GB
03 / TILBROOK, Gary, Stuart
25, Ryston End
Downham Market Norfolk PE38 9AX / GB
04 / WILTSHIRE, Hugh
6A Harmer Green Lane
Digswell Herts AL6 OAD / GB
 [2021/33]
Former [2019/23]01 / WILHELM-OGUNBIYI, Karin
Hochscheiter Str. 33
52152 Simmerath / DE
02 / BORKETT, Keith
Carren House
Meadow Lane
Houghton CAMPS PE28 2BP / GB
03 / TILBROOK, Gary, Stuart
Hunney Cottage
Short Lane
Bluntisham Huntingdon, Cambridgeshire PE28 3NS / GB
04 / WILTSHIRE, Hugh
6A Harmer Green Lane
Digswell Herts AL6 OAD / GB
Representative(s)König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB Düsseldorf
Mönchenwerther Straße 11
40545 Düsseldorf / DE
[N/P]
Former [2019/23]von Renesse, Dorothea, et al
König-Szynka-Tilmann-von Renesse
Patentanwälte Partnerschaft mbB
Mönchenwerther Str. 11
40545 Düsseldorf / DE
Application number, filing date19150745.807.11.2011
[2019/23]
Priority number, dateEP2010001436608.11.2010         Original published format: EP 10014366
EP2010001478419.11.2010         Original published format: EP 10014784
EP2010001481922.11.2010         Original published format: EP 10014819
EP2010001497225.11.2010         Original published format: EP 10014972
[2019/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3492080
Date:05.06.2019
Language:EN
[2019/23]
Search report(s)(Supplementary) European search report - dispatched on:EP10.04.2019
ClassificationIPC:A61K31/4468, A61K31/5517, A61P25/20, A61P25/04, A61K9/00
[2019/23]
CPC:
A61K31/5517 (EP,KR,US); C07D243/14 (KR); A61K31/4468 (EP,US);
A61K45/06 (EP,US); A61K9/0019 (US); A61P25/00 (EP);
A61P25/04 (EP); A61P25/20 (EP) (-)
C-Set:
A61K31/4468, A61K2300/00 (US,EP);
A61K31/5517, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/02]
Former [2019/23]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:DOSIERSCHEMA ZUR SEDIERUNG MIT CNS 7056 (REMIMAZOLAM)[2019/23]
English:DOSING REGIMEN FOR SEDATION WITH CNS 7056 (REMIMAZOLAM)[2019/23]
French:RÉGIME DE DOSAGE PERMETTANT LA SÉDATION AVEC CNS 7056 (REMIMAZOLAM)[2019/23]
Examination procedure03.12.2019Amendment by applicant (claims and/or description)
03.12.2019Examination requested  [2020/02]
03.12.2019Date on which the examining division has become responsible
29.05.2020Despatch of a communication from the examining division (Time limit: M06)
02.11.2020Reply to a communication from the examining division
18.10.2021Date of oral proceedings
26.11.2021Minutes of oral proceedings despatched
30.11.2021Despatch of communication that the application is refused, reason: substantive examination [2023/51]
08.09.2023Application refused, date of legal effect [2023/51]
Appeal following examination08.02.2022Appeal received No.  T1161/22
08.02.2022Payment of appeal fee
11.04.2022Statement of grounds filed
08.09.2023Result of appeal procedure: appeal of the applicant was rejected
27.10.2023Despatch of the decision of the Board of Appeal
08.09.2023Date of oral proceedings
Parent application(s)   TooltipEP11794020.5  / EP2637662
Fees paidRenewal fee
08.01.2019Renewal fee patent year 03
08.01.2019Renewal fee patent year 04
08.01.2019Renewal fee patent year 05
08.01.2019Renewal fee patent year 06
08.01.2019Renewal fee patent year 07
08.01.2019Renewal fee patent year 08
21.11.2019Renewal fee patent year 09
26.11.2020Renewal fee patent year 10
23.11.2021Renewal fee patent year 11
21.11.2022Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD]WO2008007081  (CENES LTD [GB], et al) [YD] 1-13 * page 5, lines 15-17 ** page 6, line 22 - page 7, line 11 *;
 [Y]  - Anonymous, "Dose-finding safety study evaluating CNS 7056 in patients undergoing diagnostic upper GI endoscopy", (20100908), pages 1 - 5, ClinicalTrials.gov, URL: http://www.clinicaltrials.gov/ct2/show/NCT00869440?term=cns+7056&rank=2, (20111115), XP002663635 [Y] 1-13 * the whole document *
by applicantEP1183243
 WO2008007071
 WO2008007081
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.